From Research to Investing with 8VC's David Moskowitz

David Moskowitz sits down with Daniel Haders II, Ph.D. in Episode 1 of our four-part series on finding the right moment to act, and when the moment chooses you. David talks about how being in the right place, at the right time, with the right mindset enabled his professional ascension from research to investing.

IN TODAY’S EPISODE YOU WILL LEARN:

  1. How David made his way into the world of venture from the world of medical research and how that led to him scaling the venture ladder to now being Principal at 8VC, one of the leading firms of the last decade?

  2. How did David, an integral member of the 8VC team, approach developing the Bio-IT investment thesis? How did the simple question of asking ‘Why now?’ lead to some of his most exciting investment opportunities?

  3. How does David view the convergence of biological data and software and its impact on the advances in biology and innovations in digital health?

David Moskowitz focuses on the Bio-IT space. Prior to joining 8VC, David completed his Ph.D. in Biomedical Informatics at Stanford University, where he concurrently received an M.S. in Statistics. His research focused on the development of statistical and machine learning approaches for analyzing genomics data, and the characterization of epigenetic changes associated with aging in T cells. Previously, David was a Bioinformatic Analyst at Einstein College of Medicine, where he worked on the genetics of aging and human disease. He performed his undergraduate studies in Computational Biology at Brown University.

LISTEN TO THE ENTIRE INTERVIEW SERIES

Previous
Previous

David Moskowitz on 8VC's Bio-IT Investments

Next
Next

Model Medicines announces AI-driven drug discovery partnership with Sanford Burnham Prebys